Literature DB >> 21725171

Improvement in strength following resistance training in MS patients despite varied disability levels.

Mary L Filipi1, Daryl L Kucera, Eric O Filipi, Alanson C Ridpath, M Patricia Leuschen.   

Abstract

Strength and endurance data from 67 participants with multiple sclerosis (MS) were compared before, during and after a 6-month program of standardized resistance training. The hypothesis was that a standardized, structured resistance training exercise program improves strength in MS patients with different levels of disability. The range of EDSS scores was 1-8: (40% - EDSS of 1-4.5), (35% - EDSS of 5-7) (25% - EDSS of 7.5 or higher). This unique study evaluated patients with differing levels of disability for a change in strength and endurance following a 6-month training program. Data were analyzed by repeat measures and analysis of variables using Proc GLM in SAS to account for variability between subjects, and within subjects, due to repeated measures at 3 time points. Each treatment was blocked by disability class. Every within-treatment analysis was significant. Each exercise showed significant improvement in strength for participants, despite disability levels. Increases in strength followed parallel improvement pathways, at all disability levels. All but one treatment displayed highly significant improvement (p-value < 0.0001). The results demonstrated that all individuals with MS, despite disability levels, show parallel improvement in strength and endurance. This study supports the use of exercise, including resistance programs, for all MS patients.

Entities:  

Mesh:

Year:  2011        PMID: 21725171     DOI: 10.3233/NRE-2011-0666

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  8 in total

1.  Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.

Authors:  Herb Karpatkin; Adam Rzetelny
Journal:  Int J MS Care       Date:  2012

2.  Time course of strength adaptations following high-intensity resistance training in individuals with multiple sclerosis.

Authors:  A Manca; Z Dvir; D Dragone; G Mureddu; G Bua; Franca Deriu
Journal:  Eur J Appl Physiol       Date:  2017-03-01       Impact factor: 3.078

3.  Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Authors:  Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

4.  Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.

Authors:  Y C Learmonth; E A Hubbard; E McAuley; R W Motl
Journal:  Qual Life Res       Date:  2014-02-14       Impact factor: 4.147

5.  Effects of Treadmill Training on Muscle Oxidative Capacity and Endurance in People with Multiple Sclerosis with Significant Walking Limitations.

Authors:  T Bradley Willingham; Jonathan Melbourn; Marina Moldavskiy; Kevin K McCully; Deborah Backus
Journal:  Int J MS Care       Date:  2019 Jul-Aug

6.  A pilot study of an exercise-based patient education program in people with multiple sclerosis.

Authors:  Stephanie Kersten; Mohammed Mahli; Julia Drosselmeyer; Christina Lutz; Magnus Liebherr; Patric Schubert; Christian T Haas
Journal:  Mult Scler Int       Date:  2014-12-21

7.  A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.

Authors:  Alon Kalron; Dalia Nitzani; David Magalashvili; Mark Dolev; Shay Menascu; Yael Stern; Uri Rosenblum; Diana Pasitselsky; Lior Frid; Gabi Zeilig; Caroline Barmatz; Uri Givon; Anat Achiron
Journal:  BMC Neurol       Date:  2015-03-04       Impact factor: 2.474

8.  Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.

Authors:  Claudia H Marck; Emily J Hadgkiss; Tracey J Weiland; Dania M van der Meer; Naresh G Pereira; George A Jelinek
Journal:  BMC Neurol       Date:  2014-07-12       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.